The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Certainly are - down 55% through boredom. What happened to investing?
What Craig is made off as sentiment has been shot to pieces.
And no regulatory body involved - FDA - is a massive tick - billions $ cos have vanished with the FDA process [and the ages it takes]
The material is easy if not time consuming to test - its every single permutation of heart actions -20-300 beats per minute , the destruction test [pressure when tears] and enhanced degradation.
Its basically the same as testing an engine - which takes about 6 months [
Correct, its MTA partner approval i.e they like it. {no nasty FDA!}
Cash Position
Strong cost management, together with the anticipated recovery in trading during the second half, means the Company remains financially resilient, with a strong balance sheet and a cash position of approximately £4.0m. Despite challenging trading conditions, these achievements underscore the Group's resilience and adeptness in financial and operational management.
Before this statement there was £2.2m rev and costs £3.1m. So its poss the co may become profitable at the end of the year.
Profitable life sciences at EV£3m do not exist - multiple earning valuations kick in so this is not a one rev co
The Options will vest in three instalments and will have an exercise period of five years. The first tranche
will vest when the closing mid-market share price reaches 7.5 pence or above for three consecutive trading
days. The second tranche will vest when the share price reaches 12.5 pence. The third tranche will vest when
the share price reaches 17.5 pence. .
Thought the tide was turning until the 70k and 250k sell at the close.
Gonna take a bit longer to get sentiment back
Volume is derisory for the drop. IMO there's a few trying to test how far it can drop..
The model is still excellent [ recurring rev and insurer marketing]- smart meters are totally different - so that was just a ruse. Insurance!!. I can only assume it has dropped 50% this year as we haven't has new contracts every month, along with a bit of boredom and a bit of botty wobbling.
£15m written off because they are growing cautiously - GLA
None apart from it being shorted to death on Nas listing because it was a spac listing
Be careful - MDAI moved to nasdaq at 60p, now 17p. Shorts kill smaller tech
$23m for a co with FDA breakthrough tech, no competition, $15b market and $250m gov funding for US rollout.
Remember, 11p was the placing price in Dec; the placing where they bit the bullet to get 4 years of funding sorted.
Currently an EV of £3.2m - that's an insane value disconnect for rev generating with world's leading tech. Just under the radar atm